Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

1298 projects found matching your search criteria :

  1. The effects of myofascial release of the diaphragm and chest on the functional parameters of the lungs and characteristi...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Magdalena Weronika Domin

    Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach

  2. Effects of activation of cholinergic, noradrenergic, and serotonergic systems on respiratory impairment in Alzheimer's d...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Kaczyńska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  3. The assessment of purity and identity confirmation of extracellular vesicles withcapillary electrophoresis

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Aleksandra Steć

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  4. Assessment of the ability of Mycobacterium bovis BCG-onko bacilli to control the development of Helicobacter pylori infe...

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Weronika Gonciarz

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  5. Environmental and epigenetic modifications and atopy and allergic diseases prevention in rural population at all ages - ...

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr hab. Barbara Ewa Sozańska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  6. Customized DNA-based nanocarriers to boost heart healing

    Call: M-ERA.NET 2022 , Panel: NZ7

    Principal investigator: dr Monika Bzowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  7. Assessment of the risk of tolerance, resistance and co-selection under various stress conditions in Escherichia coli.

    Call: SONATA 18 , Panel: NZ7

    Principal investigator: dr Aleksandra Małgorzata Rapacka-Zdończyk

    Uniwersytet Gdański, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego

  8. Targeted poloxamer micelles with selected drugs as a strategy for overcoming the mechanisms of multidrug resistance in p...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  9. Effects of tyrosine kinase inhibitors on Syk pathway in eNOS-based platelet subpopulations and on endothelial barrier in...

    Call: POLONEZ BIS 3 , Panel: NZ7

    Principal investigator: dr hab. Aneta Iwona Radziwon-Balicka

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  10. Evaluation of anti-neoplastic activity of LAB-derived postbiotics as a potential tool to support standard chemotherapy i...

    Call: PRELUDIUM BIS 4 , Panel: NZ7

    Principal investigator: prof. Janusz Zbigniew Szemraj

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

  11. Potential of TH cell profiling in personalized multiple sclerosis treatmentplanning.

    Call: OPUS 24 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Donskow-Łysoniewska

    Uczelnia Łazarskiego

  12. unESKAPEable. Innovative antibiotics leads based on bifunctionalsed metallacarboranes to combat ESKAPE pathogens.

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Jakub Cebula

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  13. Understanding the contribution of immunoproteasome activation to the neuropathic pain development.

    Call: OPUS 25 , Panel: NZ7

    Principal investigator: dr Natalia Eleonora Małek-Chudzik

    Politechnika Wrocławska

  14. Neuroprotective effect of SGLT2i: direct influence on amyloid-β related pathology

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Agnieszka Pawlos

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  15. Evaluating the antibacterial activity of the bacteriophage protein targeting Staphylococcus aureus, including drug-resis...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Zuzanna Maria Kaźmierczak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  16. Application of superparamagnetic iron oxide nanoparticles (SPION) in inhaled theranostic systems containing antifungal d...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Gabriela Małgorzata Wyszogrodzka-Gaweł

    Uniwersytet Jagielloński, Collegium Medicum

  17. First-in-class dual modulators of necroptosis kinases and 5-HT6 receptors as an innovative approach to develop an effect...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński, Collegium Medicum

  18. New biomimetic 3D materials for potential use in advanced therapies of bone tissue diseases - 3D BioBone

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Joanna Krystyna Kolmas

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  19. Synthesis, characterization, and evaluation of the biological activity of innovative thermosensitive suppositories compr...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Ewa Olędzka

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

  20. Taming aggregation with AmyloGraph 2.0: a database and prediction models of amyloid self-assembly modulators

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Michał Jan Burdukiewicz

    Uniwersytet Medyczny w Białymstoku

  21. Investigating the neurobiological mechanisms of the anti-addictive effects of psychedelics

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Adam Hamed

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  22. Analysis of organ toxicity in ultrahigh dose-rate radiotherapy (FLASH)

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Julian Czesław Malicki

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  23. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Damian Nestor Plażuk

    Uniwersytet Łódzki

  24. A Compound Screening Platform for the Discovery of Histone- and Nucleosome-Targeting Agents

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Curtis Davey

    Uniwersytet Jagielloński

  25. Assessment of long-term effects of semaglutide administered in repeated short cycles in obese mice

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Jakub Łukasz Wojcieszak

    Uniwersytet Medyczny w Łodzi

  26. Study of the effectiveness of graphene oxide-enriched hydrogels in the normalization process of postoperative adhesion

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Wiktoria Anna Frączek

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

  27. Decoding novel O/K loci of Klebsiella pneumoniae into chemical O/K antigen structures – towards better adjustment of bac...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Jolanta Katarzyna Łukasiewicz

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  28. The Potential of Mycobacterium tuberculosis Phase-Specific Antigens for Targeted TB Diagnosis

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr Shima Mahmoudi

    Politechnika Śląska

  29. 4B for LDs: Biodiversity, Biogenesis, Biodegradation and Biomedicine of lipid droplets in age-dependent vascular dysfunc...

    Call: SONATA BIS 14 , Panel: NZ7

    Principal investigator: dr hab. Marta Zofia Pacia

    Uniwersytet Jagielloński

  30. Biomimetic scaffolds modified with ferulic acid dedicated to necrotic wound therapy

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Beata Kaczmarek-Szczepańska

    Uniwersytet Mikołaja Kopernika

  31. Porous bioglass-alginate composite granules as the antibiotic delivery system with therapeutic and regenerative potentia...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Adrian Szewczyk

    Gdański Uniwersytet Medyczny

  32. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  33. Positioning the aryl hydrocarbon receptor (AhR) as a new target for pharmacotherapy of sporadic Alzheimer disease: verif...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kajta

    Instytut Farmakologii PAN

  34. Lactoferrin and versatile polymers as a tool for selective and targeted delivery of anticancer hydrophobic drugs in the ...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Przemysław Krzysztof Gajda-Morszewski

    Uniwersytet Jagielloński, Wydział Chemii

  35. Novel bispecific G-quadruplex conjugates as potential anticancer agents

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: dr Carolina Sofia Pereira Roxo

    Instytut Chemii Bioorganicznej PAN

  36. Gamma-glutamylcysteine ligase participation in the antioxidant mechanism of action of sulodexide on vascular endothelial...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Klaudia Katarzyna Bontor

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

  37. Investigation of molecular mechanisms of rapid antidepressant action of NLX-101, a biased agonist of the 5-HT1A receptor...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii PAN

  38. Strategies to protect against methamphetamine-induced neurotoxicity

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Michał Jan Toborek

    Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach, Instytut Fizjoterapii i Nauk o Zdrowiu

  39. Influence of modified maternal diet on the phenotype of offspring: behavioral and molecular correlations

    Call: ETIUDA 8 , Panel: NZ7

    Principal investigator: Kinga Eryka Gawlińska

    Instytut Farmakologii PAN

  40. Processing fluid: A new laboratory tool for diagnostic and basic investigation

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Hanna Marta Turlewicz-Podbielska

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Medycyny Weterynaryjnej i Nauk o Zwierzętach

  41. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Andrzej Mikołaj Pilc

    Instytut Farmakologii PAN

  42. Effect of time-restricted eating and endurance training on markers of the health of elderly women

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Jędrzej Antosiewicz

    Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej

  43. Anti-Candida effect and chemical characterization of the polysaccharide-protein fraction of Dendrobaena veneta earthworm...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Marta Julia Fiołka

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

  44. Evaluation of the potential use of noble metal nanoparticles as drug delivery platforms in an experimental model of infl...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Karol Paweł Steckiewicz

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  45. Bioremediation of water pollution caused by drugs and cosmetics by Cunninghamella fungi - a biotechnological strategy fo...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr Karolina Anna Słoczyńska

    Uniwersytet Jagielloński, Collegium Medicum

  46. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

  47. DNA polymerase θ as a novel therapeutic target in personalized anticancer therapy

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  48. Searching for the molecular bases of mephedrone-induced biphasic response to social interactions in rats

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: dr Olga Iga Wronikowska-Denysiuk

    Uniwersytet Medyczny w Lublinie, Wydział Nauk Medycznych

  49. Rise or fall? Short and longterm health and psychosocial trajectories of COVID-19 pandemics.

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Karol Adam Kamiński

    Uniwersytet Medyczny w Białymstoku

  50. Electroporation-based manipulation of drug resistance in cancer using novel nanosecondasymmetrical pulse sequences

    Call: DAINA 2 , Panel: NZ7

    Principal investigator: dr hab. Julita Kulbacka

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Farmaceutyczny